Randomized phase II non-inferiority study (no16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer

A. U. Buzdar, B. Xu, R. Digumarti, L. Goedhals, X. Hu, V. Semiglazov, S. Cheporov, E. Gotovkin, S. Hoersch, K. Rittweger, D. W. Miles, J. O'shaughnessy, S. Tjulandin

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II non-inferiority study (no16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences